A Live <italic toggle="yes">Salmonella</italic> Vaccine Delivering PcrV through the Type III Secretion System Protects against <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content>

ABSTRACT Pseudomonas aeruginosa is a common Gram-negative opportunistic pathogen that is intrinsically resistant to a wide range of antibiotics. The development of a broadly protective vaccine against P. aeruginosa remains a major challenge. Here, we used an attenuated strain of Salmonella enterica...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Julia Aguilera-Herce, Meritxell García-Quintanilla, Rocío Romero-Flores, Michael J. McConnell, Francisco Ramos-Morales
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2019
Materias:
Acceso en línea:https://doaj.org/article/3fce0107b7e245e5af8273bc78aa2172
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3fce0107b7e245e5af8273bc78aa2172
record_format dspace
spelling oai:doaj.org-article:3fce0107b7e245e5af8273bc78aa21722021-11-15T15:22:21ZA Live <italic toggle="yes">Salmonella</italic> Vaccine Delivering PcrV through the Type III Secretion System Protects against <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content>10.1128/mSphere.00116-192379-5042https://doaj.org/article/3fce0107b7e245e5af8273bc78aa21722019-04-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSphere.00116-19https://doaj.org/toc/2379-5042ABSTRACT Pseudomonas aeruginosa is a common Gram-negative opportunistic pathogen that is intrinsically resistant to a wide range of antibiotics. The development of a broadly protective vaccine against P. aeruginosa remains a major challenge. Here, we used an attenuated strain of Salmonella enterica serovar Typhimurium as a vehicle to express P. aeruginosa antigens. A fusion between the S. enterica type III secretion effector protein SseJ and the P. aeruginosa antigen PcrV expressed under the control of the sseA promoter was translocated by Salmonella into host cells in vitro and elicited the generation of specific antibodies in mice. Mice immunized with attenuated Salmonella expressing this fusion had reduced bacterial loads in the spleens and lungs and lower serum levels of proinflammatory cytokines than control mice after P. aeruginosa infection. Importantly, immunized mice also showed significantly enhanced survival in this model. These results suggest that type III secretion effectors of S. enterica are appropriate carriers in the design of a live vaccine to prevent infections caused by P. aeruginosa. IMPORTANCE The Gram-negative bacterium Pseudomonas aeruginosa is an important opportunistic pathogen that causes infections in cystic fibrosis and hospitalized patients. Therapeutic treatments are limited due to the emergence and spread of new antibiotic-resistant strains. In this context, the development of a vaccine is a priority. Here, we used an attenuated strain of Salmonella enterica serovar Typhimurium as a vehicle to express and deliver the Pseudomonas antigen PcrV. This vaccine induced the generation of specific antibodies in mice and protected them from lethal infections with P. aeruginosa. This is an important step toward the development of an effective vaccine for the prevention of infections caused by P. aeruginosa in humans.Julia Aguilera-HerceMeritxell García-QuintanillaRocío Romero-FloresMichael J. McConnellFrancisco Ramos-MoralesAmerican Society for MicrobiologyarticlePcrVPseudomonas aeruginosaSalmonella-delivered vaccinesSseJtype III secretionMicrobiologyQR1-502ENmSphere, Vol 4, Iss 2 (2019)
institution DOAJ
collection DOAJ
language EN
topic PcrV
Pseudomonas aeruginosa
Salmonella-delivered vaccines
SseJ
type III secretion
Microbiology
QR1-502
spellingShingle PcrV
Pseudomonas aeruginosa
Salmonella-delivered vaccines
SseJ
type III secretion
Microbiology
QR1-502
Julia Aguilera-Herce
Meritxell García-Quintanilla
Rocío Romero-Flores
Michael J. McConnell
Francisco Ramos-Morales
A Live <italic toggle="yes">Salmonella</italic> Vaccine Delivering PcrV through the Type III Secretion System Protects against <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content>
description ABSTRACT Pseudomonas aeruginosa is a common Gram-negative opportunistic pathogen that is intrinsically resistant to a wide range of antibiotics. The development of a broadly protective vaccine against P. aeruginosa remains a major challenge. Here, we used an attenuated strain of Salmonella enterica serovar Typhimurium as a vehicle to express P. aeruginosa antigens. A fusion between the S. enterica type III secretion effector protein SseJ and the P. aeruginosa antigen PcrV expressed under the control of the sseA promoter was translocated by Salmonella into host cells in vitro and elicited the generation of specific antibodies in mice. Mice immunized with attenuated Salmonella expressing this fusion had reduced bacterial loads in the spleens and lungs and lower serum levels of proinflammatory cytokines than control mice after P. aeruginosa infection. Importantly, immunized mice also showed significantly enhanced survival in this model. These results suggest that type III secretion effectors of S. enterica are appropriate carriers in the design of a live vaccine to prevent infections caused by P. aeruginosa. IMPORTANCE The Gram-negative bacterium Pseudomonas aeruginosa is an important opportunistic pathogen that causes infections in cystic fibrosis and hospitalized patients. Therapeutic treatments are limited due to the emergence and spread of new antibiotic-resistant strains. In this context, the development of a vaccine is a priority. Here, we used an attenuated strain of Salmonella enterica serovar Typhimurium as a vehicle to express and deliver the Pseudomonas antigen PcrV. This vaccine induced the generation of specific antibodies in mice and protected them from lethal infections with P. aeruginosa. This is an important step toward the development of an effective vaccine for the prevention of infections caused by P. aeruginosa in humans.
format article
author Julia Aguilera-Herce
Meritxell García-Quintanilla
Rocío Romero-Flores
Michael J. McConnell
Francisco Ramos-Morales
author_facet Julia Aguilera-Herce
Meritxell García-Quintanilla
Rocío Romero-Flores
Michael J. McConnell
Francisco Ramos-Morales
author_sort Julia Aguilera-Herce
title A Live <italic toggle="yes">Salmonella</italic> Vaccine Delivering PcrV through the Type III Secretion System Protects against <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content>
title_short A Live <italic toggle="yes">Salmonella</italic> Vaccine Delivering PcrV through the Type III Secretion System Protects against <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content>
title_full A Live <italic toggle="yes">Salmonella</italic> Vaccine Delivering PcrV through the Type III Secretion System Protects against <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content>
title_fullStr A Live <italic toggle="yes">Salmonella</italic> Vaccine Delivering PcrV through the Type III Secretion System Protects against <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content>
title_full_unstemmed A Live <italic toggle="yes">Salmonella</italic> Vaccine Delivering PcrV through the Type III Secretion System Protects against <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content>
title_sort live <italic toggle="yes">salmonella</italic> vaccine delivering pcrv through the type iii secretion system protects against <named-content content-type="genus-species">pseudomonas aeruginosa</named-content>
publisher American Society for Microbiology
publishDate 2019
url https://doaj.org/article/3fce0107b7e245e5af8273bc78aa2172
work_keys_str_mv AT juliaaguileraherce aliveitalictoggleyessalmonellaitalicvaccinedeliveringpcrvthroughthetypeiiisecretionsystemprotectsagainstnamedcontentcontenttypegenusspeciespseudomonasaeruginosanamedcontent
AT meritxellgarciaquintanilla aliveitalictoggleyessalmonellaitalicvaccinedeliveringpcrvthroughthetypeiiisecretionsystemprotectsagainstnamedcontentcontenttypegenusspeciespseudomonasaeruginosanamedcontent
AT rocioromeroflores aliveitalictoggleyessalmonellaitalicvaccinedeliveringpcrvthroughthetypeiiisecretionsystemprotectsagainstnamedcontentcontenttypegenusspeciespseudomonasaeruginosanamedcontent
AT michaeljmcconnell aliveitalictoggleyessalmonellaitalicvaccinedeliveringpcrvthroughthetypeiiisecretionsystemprotectsagainstnamedcontentcontenttypegenusspeciespseudomonasaeruginosanamedcontent
AT franciscoramosmorales aliveitalictoggleyessalmonellaitalicvaccinedeliveringpcrvthroughthetypeiiisecretionsystemprotectsagainstnamedcontentcontenttypegenusspeciespseudomonasaeruginosanamedcontent
AT juliaaguileraherce liveitalictoggleyessalmonellaitalicvaccinedeliveringpcrvthroughthetypeiiisecretionsystemprotectsagainstnamedcontentcontenttypegenusspeciespseudomonasaeruginosanamedcontent
AT meritxellgarciaquintanilla liveitalictoggleyessalmonellaitalicvaccinedeliveringpcrvthroughthetypeiiisecretionsystemprotectsagainstnamedcontentcontenttypegenusspeciespseudomonasaeruginosanamedcontent
AT rocioromeroflores liveitalictoggleyessalmonellaitalicvaccinedeliveringpcrvthroughthetypeiiisecretionsystemprotectsagainstnamedcontentcontenttypegenusspeciespseudomonasaeruginosanamedcontent
AT michaeljmcconnell liveitalictoggleyessalmonellaitalicvaccinedeliveringpcrvthroughthetypeiiisecretionsystemprotectsagainstnamedcontentcontenttypegenusspeciespseudomonasaeruginosanamedcontent
AT franciscoramosmorales liveitalictoggleyessalmonellaitalicvaccinedeliveringpcrvthroughthetypeiiisecretionsystemprotectsagainstnamedcontentcontenttypegenusspeciespseudomonasaeruginosanamedcontent
_version_ 1718428004275716096